2004
|
||
|---|---|---|
|
January
January; 43 (1): 1 - 117 |
February
February; 43 (2): 119 - 261 Supplement: The LOX/COX pathway: challenging the management of osteoarthritis Supported by an restricted educational grant from Merckle GmbH and its EuroAlliance Partners Alfa Wassermann S.p.A and Lácer S.A. |
March
March; 43 (3): 263 - 403 |
|
April
April; 43 (4): 405 - 541 Supplement: British Society for Rheumatology Annual Meeting 20-23 April 2004 Edinburgh, Scotland and British Health Professionals Spring Meeting 21-23 April 2004 Edinburgh, Scotland |
May
May; 43 (5): 543 - 686 |
June
Supplement: The role of interleukin-1 in rheumatoid arthritis Supported by an unrestricted educational grant from Amgen June; 43 (6): 687 - 817 |
|
July
July; 43 (7): 819 - 942 |
August
August; 43 (8): 943 - 1065 |
September
September; 43 (9): 1067 - 1204 |
|
October
October; 43 (10): 1205 - 1320 |
November
November; 43 (11): 1321 - 1462 |
December
December; 43 (12): 1463 - 1601 |